Login to Your Account


Potential deal value $2.1B

Shares in Almirall SA rose 9 percent Wednesday on news that Astrazeneca plc is paying $875 million up front to acquire its respiratory disease portfolio of partnered and pipeline assets. A further $1.22 billion in milestones is attached to the deal. more »


Opinion


Partners in Focus